Thyroid Eye Disease Cosmetic Management in Korea: Orbital Decompression and Beyond

Thyroid eye disease (TED), also called Graves\' orbitopathy, produces eye-bulging (proptosis), eyelid retraction, and other disfiguring changes that have profound cosmetic and psychological impact. Korean ophthalmic plastic surgery offers comprehensive management — from medical treatment in active disease to orbital decompression and cosmetic eyelid procedures in stable disease. This guide covers the Korean approach.

What thyroid eye disease is

• Autoimmune inflammation of orbital tissues.
• Associated with Graves\' disease (hyperthyroidism).
• Can occur with normal or hypothyroid status.
• Inflammation enlarges extraocular muscles and orbital fat.
• Pushes eye forward (proptosis), retracts eyelids, restricts eye movement.

Disease phases

Active phase

• Inflammation present.
• Worsening symptoms over months.
• Medical treatment indicated.
• Cosmetic surgery generally deferred.
• Duration: typically 6–24 months.

Stable/inactive phase

• Inflammation resolved.
• Stable findings for 6+ months.
• Surgical intervention considered.
• Cosmetic surgery now appropriate.

Common cosmetic concerns

• Eye bulging (proptosis) — most prominent visual feature.
• Upper eyelid retraction — "staring" or surprised appearance.
• Lower eyelid retraction with scleral show below iris.
• Bag-like swelling under eyes.
• Asymmetric appearance (often one side worse).
• Functional issues: dry eye, exposure, blurred vision.

Medical treatment (active phase)

First-line

• Intravenous glucocorticoids (most common in Korea).
• Korean survey: 96.9% use IV steroids for moderate-to-severe disease.
• Reduces inflammation and proptosis progression.
• Side effects monitored.

Second-line

• Orbital radiotherapy.
• Adjunctive in 90% of moderate-to-severe Korean cases.
• Combined with steroids often.
• Reduces inflammation and fibrosis.

Newer therapies

• Teprotumumab — newer biologic targeting inflammatory pathway.
• Korean availability limited; cost barrier significant.
• Reserved for refractory cases primarily.
• Rituximab in selected cases.

Korean ophthalmic plastic surgery practice

Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS)

• National specialist organization.
• 87.5% of members use Clinical Activity Score for assessment.
• European Group on Graves\' Orbitopathy classification standard.
• Standardized practice across major centers.

Treatment hierarchy

• Active disease: medical treatment.
• Stable disease with proptosis: orbital decompression.
• After decompression: strabismus surgery if needed.
• After strabismus: eyelid surgery.
• Order matters — each procedure affects subsequent ones.

Orbital decompression surgery

What it is

• Removal of bony orbital walls and/or orbital fat.
• Creates more space for orbital contents.
• Allows eye to retract back to normal position.
• Reduces proptosis substantially.

Approaches

• Medial wall decompression — bone removal toward nose.
• Lateral wall decompression — bone removal toward temple.
• Floor decompression — bone removal toward sinus.
• Fat decompression — orbital fat removal.
• Combinations based on individual case.

Indications

• Optic nerve compression (urgent).
• Severe proptosis.
• Cosmetic disfigurement after stable disease.
• Exposure keratopathy.
• Progressive proptosis despite medical management.

Eyelid surgery for TED

Upper eyelid retraction repair

• Müller\'s muscle myectomy.
• Levator aponeurosis recession.
• Müller\'s muscle blepharotomy.
• Restores normal eyelid position.
• Less aggressive than full ptosis repair.

Lower eyelid retraction repair

• Lower lid recession with spacer graft.
• Hard palate mucosa or alloplastic material.
• Elevates lower lid to cover sclera.
• Reduces "staring" appearance.

Cosmetic blepharoplasty after TED

• Conservative skin and fat work after stable disease.
• Combined with retraction repair.
• Restoration of natural eyelid contour.
• Subtle, age-appropriate result.

Strabismus surgery

When indicated

• Eye misalignment after orbital decompression.
• Double vision (diplopia).
• Restrictive strabismus from inflamed muscles.
• Performed after orbital decompression typically.

Technique

• Adjustable suture technique often.
• Recession of restricted muscles.
• Restoration of binocular single vision.
• Conservative approach preferred.

Korea as destination for TED

Strengths

• Specialized ophthalmic plastic surgery training.
• Experience with combined surgical management.
• Standardized treatment protocols.
• 3D imaging for surgical planning.
• Comprehensive medical-surgical coordination.

Limitations

• Teprotumumab less available than US.
• Insurance coverage for foreign patients limited.
• Long-term follow-up logistics.
• Multi-stage treatment requires multiple visits.

Patient pathway

Pre-treatment evaluation

• Clinical Activity Score assessment.
• European severity classification.
• Imaging (CT or MRI).
• Optic nerve function evaluation.
• Eye motility examination.
• Coordination with endocrinology.

Active disease management

• Medical treatment series.
• Monitoring for progression.
• Eye protection (lubrication, sleeping with elevated head).
• Wait for stable disease.

Surgical treatment sequence

• Orbital decompression first if indicated.
• Allow 6+ months for healing.
• Strabismus surgery if needed.
• Eyelid retraction repair.
• Cosmetic refinement last.

Pricing considerations

• Orbital decompression: ₩6,000,000–₩15,000,000 per side.
• Strabismus surgery: ₩3,000,000–₩6,000,000.
• Eyelid retraction repair: ₩2,500,000–₩5,000,000 per lid.
• Multi-stage treatment significantly more.
• USD: $5,000–$25,000+ depending on extent.

Recovery and outcomes

• Substantial improvement possible.
• Multi-stage treatment over 12–24 months typical.
• Each procedure with own recovery (2–6 weeks).
• Final result represents major improvement from disease state.
• Not always "completely normal" appearance.

For international patients

• Consider whether multi-stage treatment in Korea logistically feasible.
• Coordinate with home endocrinologist.
• Bring imaging and disease records.
• Consider initial consultation followed by treatment planning trip.
• Long-term follow-up at home.

The honest framing

Thyroid eye disease produces some of the most disfiguring facial changes in cosmetic medicine, with profound psychological impact. Korean ophthalmic plastic surgery offers comprehensive multi-stage management — but treatment requires patience (waiting for disease stability), commitment (multiple staged procedures), and realistic expectations (substantial improvement, not always complete normalization). The patients who get the best outcomes work with TED-experienced specialists, follow the standard treatment sequence, and accept the multi-stage timeline. The patients who pursue cosmetic eyelid surgery during active disease, or out of standard sequence, often face suboptimal results and revisions. Korea offers excellent TED management for those willing to commit to the comprehensive process.